Stripe, Anthropic, and OpenAI back $500M nonprofit to prevent cold and flu
A new nonprofit funded by Stripe, Anthropic, and OpenAI aims to eliminate respiratory viruses entirely.
The payment company Stripe is funding a new $500 million nonprofit aiming to prevent both the common cold and the flu. Its eventual goal is to get rid of respiratory viruses altogether. Anthropic, OpenAI, and Bill Gates have also backed the venture, which will investigate whether modern technologies can counter the common cold and the flu.
The common cold comes for us all—often more than once a year. There is no way to prevent it beyond vitamin C and avoiding sick people. This new initiative represents an ambitious attempt to use advanced biotech and AI tools to tackle a problem that has eluded science for decades. The involvement of leading AI companies suggests a focus on computational biology and drug discovery acceleration.
- Stripe, Anthropic, OpenAI, and Bill Gates are funding a $500M nonprofit to prevent cold and flu.
- The initiative aims to eliminate respiratory viruses entirely, not just manage symptoms.
- The venture will explore modern biotech and AI approaches to counter common viral infections.
Why It Matters
This cross-sector effort could revolutionize respiratory disease prevention, leveraging AI for drug discovery and vaccine development.